Turkey · Delayed Price · Currency is TRY IST:SURGY Statistics
Total Valuation
IST:SURGY has a market cap or net worth of TRY 7.95 billion. The enterprise value is 7.91 billion.
| Market Cap | 7.95B |
| Enterprise Value | 7.91B |
Important Dates
The next estimated earnings date is Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IST:SURGY has 167.50 million shares outstanding.
| Current Share Class | 165.43M |
| Shares Outstanding | 167.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.28% |
| Float | n/a |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.80 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.26
| Current Ratio | 19.26 |
| Quick Ratio | 0.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.81 |
Financial Efficiency
Return on equity (ROE) is -3.13% and return on invested capital (ROIC) is -2.05%.
| Return on Equity (ROE) | -3.13% |
| Return on Assets (ROA) | -0.97% |
| Return on Invested Capital (ROIC) | -2.05% |
| Return on Capital Employed (ROCE) | -1.38% |
| Weighted Average Cost of Capital (WACC) | 9.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 53 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IST:SURGY has paid 214.97 million in taxes.
| Income Tax | 214.97M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.90% in the last 52 weeks. The beta is 1.02, so IST:SURGY's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | -36.90% |
| 50-Day Moving Average | 68.44 |
| 200-Day Moving Average | 59.15 |
| Relative Strength Index (RSI) | 16.57 |
| Average Volume (20 Days) | 7,520,284 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -195.50M |
| Pretax Income | -62.85M |
| Net Income | -277.82M |
| EBITDA | -193.31M |
| EBIT | -195.50M |
| Earnings Per Share (EPS) | -1.66 |
Balance Sheet
The company has 36.85 million in cash and no debt, with a net cash position of 36.85 million or 0.22 per share.
| Cash & Cash Equivalents | 36.85M |
| Total Debt | n/a |
| Net Cash | 36.85M |
| Net Cash Per Share | 0.22 |
| Equity (Book Value) | 9.98B |
| Book Value Per Share | 59.56 |
| Working Capital | 2.58B |
Cash Flow
| Operating Cash Flow | -199.62M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IST:SURGY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.49% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |